MRX
Marex Group Ltd
Company overview
- Market capitalization
- —
- Employees
- 3,331
- Latest publication
- 2026-09-29
About Marex Group Ltd
Marex Group plc, a financial services platform company, provides liquidity, market access, and infrastructure services to clients in the commodity and financial markets in the United Kingdom, the United States, and internationally. It operates through Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions segments. The company offers execution and clearing services in metals, agricultural products, energy and fixed income, financial securities, digital assets, and equity futures and options; liquidity, execution, and risk management solutions to financial markets. It also provides liquidity to clients in the OTC energy markets; market data, analytics, and market commentary; energy services, including gas, power, environmental, and crude oil markets; and market-making services across commodities markets, such as metals, agricultural products, and energy markets. In addition, the company offers OTC traded hedging and customized OTC derivatives solutions; and risk management solutions across a spectrum of markets, including agriculture, currency, and interest rate markets for trading houses, producers and consumers, and banks and distributors. Further, it engages in the structured notes business, which allows investors to build structured notes across asset classes, including commodities, equities, foreign exchange, and fixed-income products for private banks, independent asset managers, pension funds, and corporates; and a portfolio of structured Notes, including auto-callable, fixed, stability, and credit-linked notes. Additionally, the company offers technology platforms, including Neon, a trading, risk, and data platform; and Agile, a commodity broking platform. Marex Group plc was incorporated in 2005 and is based in London, the United Kingdom.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,333,400,000USD | 3,129,700,000USD | 484,600,000USD | 500,100,000USD | 865,700,000USD | 2,154,800,000USD | 391,200,000USD | 740,000,000USD |
| Cost Of Revenue | 845,500,000USD | 611,800,000USD | 292,000,000USD | 305,900,000USD | 544,700,000USD | 1,158,700,000USD | 241,700,000USD | 448,900,000USD |
| Gross Profit | 487,900,000USD | 2,517,900,000USD | 192,600,000USD | 194,200,000USD | 321,000,000USD | 996,100,000USD | 391,200,000USD | 291,100,000USD |
| Unclassified Operating Expenses | 970,900,000USD | 1,457,900,000USD | 390,000,000USD | 93,400,000USD | 81,700,000USD | 159,800,000USD | -79,000,000USD | 291,100,000USD |
| Total Operating Expenses | 970,900,000USD | 1,457,900,000USD | 390,000,000USD | 93,400,000USD | 81,700,000USD | 159,800,000USD | -79,000,000USD | 291,100,000USD |
| Operating Income | 362,500,000USD | 1,060,000,000USD | 94,600,000USD | 100,800,000USD | 239,300,000USD | 437,100,000USD | 79,000,000USD | 391,200,000USD |
| Interest Expense | 216,400,000USD | 760,200,000USD | — | — | 145,400,000USD | 413,100,000USD | — | 125,000,000USD |
| Net Interest Income | -216,400,000USD | — | — | — | -145,400,000USD | — | — | -125,000,000USD |
| Income Before Tax | 149,800,000USD | 308,000,000USD | 98,800,000USD | 103,600,000USD | 98,000,000USD | 156,800,000USD | 79,000,000USD | 139,000,000USD |
| Tax Provision | 37,500,000USD | 25,700,000USD | 25,600,000USD | 26,900,000USD | 25,500,000USD | — | 20,600,000USD | 20,800,000USD |
| Net Income | 112,400,000USD | 231,500,000USD | 73,200,000USD | 76,700,000USD | 72,500,000USD | 115,100,000USD | 58,400,000USD | 102,900,000USD |
| Net Income From Continuing Ops | 112,300,000USD | 85,500,000USD | 73,200,000USD | 76,700,000USD | 72,500,000USD | 0USD | 79,000,000USD | 59,300,000USD |
| Reconciled Depreciation | 11,700,000USD | 10,000,000USD | 9,600,000USD | 8,600,000USD | 7,900,000USD | — | 6,800,000USD | 7,700,000USD |
| Total Other Income Expense Net | 3,700,000USD | -752,000,000USD | 4,200,000USD | 2,800,000USD | -141,300,000USD | -288,300,000USD | 79,000,000USD | -252,200,000USD |
| Income Tax Expense | — | 76,800,000USD | — | 26,900,000USD | 25,500,000USD | 41,700,000USD | — | 36,100,000USD |
| Ebit | — | 1,071,000,000USD | — | 100,800,000USD | 243,400,000USD | 437,100,000USD | — | 391,200,000USD |
| Ebitda | — | 1,098,500,000USD | — | 109,400,000USD | 251,300,000USD | 450,500,000USD | 79,000,000USD | 406,600,000USD |
| Depreciation And Amortization | — | 27,500,000USD | — | 8,600,000USD | 7,900,000USD | 13,400,000USD | — | 15,400,000USD |
| Minority Interest | — | — | — | — | — | — | — | -3,300,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 3,629,800,000USD | 2,894,800,000USD | 2,352,300,000USD | 1,175,300,000USD | 851,700,000USD | 757,528,000USD | 549,193,000USD | 384,466,000USD |
| Cost Of Revenue | 917,700,000USD | 1,607,600,000USD | 659,400,000USD | 313,000,000USD | 609,500,000USD | — | — | — |
| Gross Profit | 2,712,100,000USD | 1,287,200,000USD | 1,692,900,000USD | 862,300,000USD | 825,300,000USD | 757,528,000USD | 549,193,000USD | 384,466,000USD |
| Selling General Administrative | 288,800,000USD | 247,100,000USD | 182,100,000USD | 120,100,000USD | 82,500,000USD | — | — | — |
| Unclassified Operating Expenses | 1,262,500,000USD | 203,800,000USD | — | 103,000,000USD | 62,300,000USD | 700,190,000USD | 540,554,000USD | 339,165,000USD |
| Total Operating Expenses | 1,551,300,000USD | 450,900,000USD | 798,800,000USD | 223,100,000USD | 144,800,000USD | 700,953,000USD | 541,193,000USD | 339,225,000USD |
| Operating Income | 1,160,800,000USD | 836,300,000USD | 683,500,000USD | 270,500,000USD | 68,600,000USD | 56,575,000USD | 12,230,000USD | 45,241,000USD |
| Interest Expense | 760,200,000USD | 538,100,000USD | 470,200,000USD | 165,000,000USD | 26,400,000USD | — | — | — |
| Net Interest Income | -770,500,000USD | -546,800,000USD | -475,600,000USD | -169,100,000USD | -29,700,000USD | — | — | — |
| Income Before Tax | 411,600,000USD | 295,800,000USD | 196,500,000USD | 121,600,000USD | 69,900,000USD | 54,984,000USD | 46,626,000USD | 13,433,000USD |
| Income Tax Expense | 103,700,000USD | 77,800,000USD | 55,200,000USD | 23,400,000USD | 13,400,000USD | 11,161,000USD | 10,234,000USD | 3,281,000USD |
| Tax Provision | 103,700,000USD | 77,800,000USD | 55,200,000USD | 23,400,000USD | 13,400,000USD | — | — | — |
| Net Income | 308,200,000USD | 218,000,000USD | 128,000,000USD | 91,600,000USD | 56,500,000USD | 43,823,000USD | 36,392,000USD | 10,152,000USD |
| Net Income From Continuing Ops | 307,900,000USD | 218,000,000USD | 141,300,000USD | 98,200,000USD | 56,500,000USD | — | — | — |
| Ebit | 1,171,800,000USD | 837,000,000USD | 683,500,000USD | 270,500,000USD | 96,300,000USD | 54,984,000USD | 46,626,000USD | — |
| Ebitda | 1,207,900,000USD | 865,800,000USD | 705,400,000USD | 284,300,000USD | 106,600,000USD | 18,564,000USD | 34,396,000USD | — |
| Depreciation And Amortization | 36,100,000USD | 28,800,000USD | 21,900,000USD | 13,800,000USD | 10,300,000USD | -36,420,000USD | -12,230,000USD | — |
| Reconciled Depreciation | 36,100,000USD | 28,800,000USD | 21,900,000USD | 13,800,000USD | 10,300,000USD | — | — | — |
| Total Other Income Expense Net | -749,200,000USD | -540,500,000USD | -487,000,000USD | -148,900,000USD | 1,300,000USD | -1,591,000USD | 34,396,000USD | -31,808,000USD |
| Minority Interest | -500,000USD | -13,300,000USD | -13,300,000USD | -6,600,000USD | 0USD | — | — | — |
| Selling And Marketing Expenses | — | — | 616,700,000USD | — | — | — | — | — |
| Interest Income | — | — | 591,800,000USD | 194,400,000USD | 23,100,000USD | — | — | — |
| Research Development | — | — | — | — | — | 763,000USD | 639,000USD | 60,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 36,530,100,000USD | 34,675,100,000USD | 32,940,100,000USD | 31,188,300,000USD | 24,354,500,000USD | 24,312,500,000USD | 19,505,700,000USD | 17,189,400,000USD |
| Intangible Assets | 94,700,000USD | 335,400,000USD | 71,400,000USD | 66,900,000USD | 54,500,000USD | 56,500,000USD | 220,000,000USD | 53,700,000USD |
| Total Liab | 35,183,600,000USD | 33,411,500,000USD | 31,756,500,000USD | 30,077,100,000USD | 23,308,300,000USD | 23,335,600,000USD | 18,545,900,000USD | 16,307,100,000USD |
| Total Stockholder Equity | 1,348,800,000USD | 1,263,800,000USD | 1,179,500,000USD | 1,111,200,000USD | 1,046,200,000USD | 976,900,000USD | 959,800,000USD | 882,300,000USD |
| Other Current Liab | 9,995,400,000USD | 10,241,600,000USD | 9,409,600,000USD | — | 7,249,400,000USD | 9,396,100,000USD | 652,100,000USD | 5,381,000,000USD |
| Capital Stock | 100,000USD | 100,000USD | 100,000USD | — | 100,000USD | 100,000USD | — | 100,000USD |
| Retained Earnings | 1,081,700,000USD | 982,000,000USD | 896,700,000USD | 828,200,000USD | 775,300,000USD | 722,400,000USD | — | 611,200,000USD |
| Good Will | 237,200,000USD | 237,400,000USD | 248,300,000USD | 215,100,000USD | 225,000,000USD | 176,500,000USD | — | 167,400,000USD |
| Cash | 3,068,900,000USD | 6,378,000,000USD | 3,107,700,000USD | 6,908,700,000USD | 2,606,700,000USD | 2,556,600,000USD | 5,829,200,000USD | 1,914,200,000USD |
| Total Current Assets | 35,424,500,000USD | 24,527,600,000USD | 32,130,600,000USD | 21,937,500,000USD | 23,775,300,000USD | 23,828,500,000USD | 13,947,600,000USD | 16,665,200,000USD |
| Total Current Liabilities | 32,777,500,000USD | 7,753,100,000USD | 29,027,000,000USD | 16,663,300,000USD | 21,769,100,000USD | 21,779,200,000USD | 11,064,100,000USD | 15,267,300,000USD |
| Net Debt | 7,198,900,000USD | 3,789,800,000USD | 5,599,800,000USD | 1,639,800,000USD | 4,206,100,000USD | 3,583,200,000USD | -860,500,000USD | 2,454,900,000USD |
| Short Long Term Debt | 7,988,700,000USD | 7,810,400,000USD | 6,055,000,000USD | 3,290,700,000USD | 5,267,000,000USD | 4,577,400,000USD | 2,333,700,000USD | 1,844,400,000USD |
| Long Term Debt | 2,279,100,000USD | 2,327,300,000USD | 2,652,500,000USD | 5,257,800,000USD | 1,462,700,000USD | 1,484,900,000USD | 2,635,000,000USD | 971,400,000USD |
| Long Term Investments | 220,800,000USD | 111,600,000USD | 86,000,000USD | 8,533,500,000USD | 29,500,000USD | 77,500,000USD | 5,111,700,000USD | 17,500,000USD |
| Short Term Investments | 3,822,800,000USD | 7,078,600,000USD | 4,243,700,000USD | — | 2,730,300,000USD | 2,657,000,000USD | — | 2,532,600,000USD |
| Net Receivables | 10,684,500,000USD | 11,071,000,000USD | 11,042,800,000USD | 13,557,100,000USD | 9,747,100,000USD | 9,549,400,000USD | 7,109,800,000USD | 6,130,200,000USD |
| Inventory | 300,100,000USD | 483,700,000USD | 179,500,000USD | — | 104,100,000USD | 35,800,000USD | — | 123,000,000USD |
| Accounts Payable | 14,765,700,000USD | 11,781,700,000USD | 13,528,300,000USD | 13,372,600,000USD | 9,204,000,000USD | 7,741,000,000USD | 8,078,300,000USD | 6,523,300,000USD |
| Property Plant Equipment Net | 109,100,000USD | 110,900,000USD | 88,500,000USD | — | 86,800,000USD | 80,700,000USD | — | 79,000,000USD |
| Property Plant Equipment Gross | 109,100,000USD | 160,900,000USD | 88,500,000USD | — | 86,800,000USD | 126,800,000USD | — | 79,000,000USD |
| Common Stock Shares Outstanding | 71,930,870shares | 76,126,884shares | 71,699,922shares | 71,699,922shares | 78,804,348shares | 78,221,410shares | 80,000,000shares | 72,221,843shares |
| Non Current Assets Total | 1,105,600,000USD | 10,147,500,000USD | 809,500,000USD | 9,250,800,000USD | 579,200,000USD | 484,000,000USD | 5,558,100,000USD | 524,200,000USD |
| Non Current Liabilities Total | 2,406,100,000USD | 25,658,400,000USD | 2,729,500,000USD | 13,413,800,000USD | 1,539,200,000USD | 1,556,400,000USD | 7,481,800,000USD | 1,039,800,000USD |
| Non Currrent Assets Other | 353,100,000USD | 3,781,700,000USD | 294,700,000USD | 435,300,000USD | 153,900,000USD | 46,100,000USD | 226,400,000USD | 185,900,000USD |
| Net Working Capital | 2,647,000,000USD | 2,733,500,000USD | 3,103,600,000USD | 5,274,200,000USD | 2,006,200,000USD | 2,049,300,000USD | -1,857,300,000USD | 1,397,900,000USD |
| Unclassified Current Assets | 17,548,200,000USD | -483,700,000USD | 13,556,900,000USD | — | — | — | — | — |
| Unclassified Non Current Assets | 90,700,000USD | 5,570,500,000USD | 20,600,000USD | — | 29,500,000USD | 46,700,000USD | — | 20,700,000USD |
| Unclassified Non Current Liabilities | 127,000,000USD | 23,331,100,000USD | 77,000,000USD | 1,096,500,000USD | 76,500,000USD | 71,500,000USD | 4,740,800,000USD | -903,000,000USD |
| Unclassified Equity | 267,000,000USD | 266,200,000USD | 282,700,000USD | 167,700,000USD | 268,600,000USD | 276,900,000USD | 959,800,000USD | 276,900,000USD |
| Common Stock | — | 100,000USD | — | 100,000USD | 100,000USD | 100,000USD | — | 100,000USD |
| Cash And Short Term Investments | — | 13,456,600,000USD | — | 6,908,700,000USD | 5,337,000,000USD | 5,213,600,000USD | 5,829,200,000USD | 4,446,800,000USD |
| Short Term Debt | — | 7,753,100,000USD | — | 3,290,700,000USD | 5,276,700,000USD | 4,587,900,000USD | 2,333,700,000USD | 3,332,300,000USD |
| Short Long Term Debt Total | — | 10,167,800,000USD | — | 8,548,500,000USD | 6,812,800,000USD | 6,139,800,000USD | 4,968,700,000USD | 4,369,100,000USD |
| Accumulated Other Comprehensive Income | — | 15,400,000USD | — | 115,200,000USD | 2,100,000USD | -22,600,000USD | — | -6,000,000USD |
| Unclassified Current Liabilities | — | -29,833,700,000USD | — | -3,290,700,000USD | -5,228,000,000USD | -4,525,600,000USD | -2,333,700,000USD | -1,817,400,000USD |
| Other Current Assets | — | — | — | 1,471,700,000USD | 8,587,100,000USD | 9,029,700,000USD | 1,008,600,000USD | 5,965,200,000USD |
| Non Current Liabilities Other | — | — | — | 7,059,500,000USD | — | — | 106,000,000USD | 971,400,000USD |
| Other Assets | — | — | — | — | — | -21,271,900,000USD | — | — |
| Current Deferred Revenue | — | — | — | — | — | 2,400,000USD | — | 3,700,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 34,675,100,000USD | 24,312,500,000USD | 17,611,600,000USD | 15,743,900,000USD | 5,264,600,000USD | 3,766,821,000USD | 2,579,985,000USD | 1,394,911,000USD |
| Intangible Assets | 335,400,000USD | 56,500,000USD | 56,000,000USD | 25,600,000USD | 21,500,000USD | 14,346,000USD | 7,830,000USD | 1,864,000USD |
| Total Liab | 33,411,500,000USD | 23,335,600,000USD | 16,835,700,000USD | 15,066,200,000USD | 4,786,900,000USD | 3,323,033,000USD | 2,162,230,000USD | 1,012,977,000USD |
| Total Stockholder Equity | 1,263,800,000USD | 976,900,000USD | 775,900,000USD | 677,700,000USD | 477,700,000USD | 443,788,000USD | 417,755,000USD | 381,934,000USD |
| Other Current Liab | 10,241,600,000USD | 9,396,100,000USD | 6,510,500,000USD | 2,679,600,000USD | 200,300,000USD | 122,373,000USD | 84,160,000USD | — |
| Common Stock | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 23,000USD | 23,000USD | 21,000USD |
| Capital Stock | 100,000USD | 100,000USD | 100,000USD | 100,000USD | 100,000USD | — | — | — |
| Retained Earnings | 982,000,000USD | 722,400,000USD | 555,300,000USD | 455,300,000USD | 346,600,000USD | 132,641,000USD | 107,013,000USD | 72,279,000USD |
| Good Will | 237,400,000USD | 176,500,000USD | 163,600,000USD | 155,500,000USD | 208,900,000USD | 198,401,000USD | 179,175,000USD | 140,969,000USD |
| Cash | 6,378,000,000USD | 2,556,600,000USD | 1,483,500,000USD | 910,100,000USD | 712,000,000USD | 291,546,000USD | 217,501,000USD | 160,728,000USD |
| Cash And Short Term Investments | 13,456,600,000USD | 5,213,600,000USD | 4,733,000,000USD | 3,221,200,000USD | 758,300,000USD | 291,546,000USD | 217,501,000USD | — |
| Total Current Assets | 24,527,600,000USD | 23,828,500,000USD | 16,936,000,000USD | 15,354,200,000USD | 4,124,800,000USD | 291,546,000USD | 217,501,000USD | — |
| Total Current Liabilities | 7,753,100,000USD | 21,779,200,000USD | 15,884,700,000USD | 14,561,900,000USD | 4,630,100,000USD | 122,373,000USD | 84,160,000USD | — |
| Net Debt | 3,789,800,000USD | 3,583,200,000USD | 3,904,300,000USD | 4,818,900,000USD | 578,100,000USD | -44,790,000USD | -204,555,000USD | -160,728,000USD |
| Short Term Debt | 7,753,100,000USD | 4,587,900,000USD | 4,440,500,000USD | 5,224,800,000USD | 1,136,500,000USD | — | — | — |
| Short Long Term Debt | 7,810,400,000USD | 4,577,400,000USD | 3,118,900,000USD | 4,394,300,000USD | 140,400,000USD | — | — | — |
| Short Long Term Debt Total | 10,167,800,000USD | 6,139,800,000USD | 5,387,800,000USD | 5,729,000,000USD | 1,290,100,000USD | 246,756,000USD | 12,946,000USD | — |
| Long Term Debt | 2,327,300,000USD | 1,484,900,000USD | 907,900,000USD | 135,800,000USD | 136,600,000USD | — | — | — |
| Long Term Investments | 111,600,000USD | 77,500,000USD | 77,000,000USD | 22,000,000USD | 84,800,000USD | — | — | — |
| Short Term Investments | 7,078,600,000USD | 2,657,000,000USD | 3,249,500,000USD | 2,311,100,000USD | 46,300,000USD | — | — | — |
| Net Receivables | 11,071,000,000USD | 9,549,400,000USD | 7,710,100,000USD | 9,036,700,000USD | 2,173,400,000USD | — | — | — |
| Inventory | 483,700,000USD | 35,800,000USD | 163,400,000USD | 35,800,000USD | 80,100,000USD | — | — | — |
| Accounts Payable | 11,781,700,000USD | 7,741,000,000USD | 4,915,200,000USD | 6,647,600,000USD | 3,291,200,000USD | — | — | — |
| Property Plant Equipment Net | 110,900,000USD | 80,700,000USD | 57,200,000USD | 45,500,000USD | 20,900,000USD | 20,394,000USD | 27,709,000USD | 2,481,000USD |
| Property Plant Equipment Gross | 160,900,000USD | 126,800,000USD | 96,000,000USD | 78,800,000USD | 51,400,000USD | — | — | — |
| Accumulated Other Comprehensive Income | 15,400,000USD | -22,600,000USD | -1,600,000USD | -1,700,000USD | -3,300,000USD | 176,797,000USD | 176,392,000USD | 175,118,000USD |
| Common Stock Shares Outstanding | 76,126,884shares | 75,279,454shares | 72,221,843shares | 70,818,084shares | 70,818,084shares | 60,630,837shares | 60,630,837shares | 60,630,837shares |
| Non Current Assets Total | 10,147,500,000USD | 484,000,000USD | 675,600,000USD | 389,700,000USD | 1,139,800,000USD | 3,475,275,000USD | 2,362,484,000USD | 1,394,911,000USD |
| Non Current Liabilities Total | 25,658,400,000USD | 1,556,400,000USD | 951,000,000USD | 504,300,000USD | 156,800,000USD | 3,200,660,000USD | 2,078,070,000USD | 1,012,977,000USD |
| Non Currrent Assets Other | 3,781,700,000USD | 46,100,000USD | 300,400,000USD | 133,500,000USD | 799,700,000USD | 3,242,134,000USD | 2,147,770,000USD | 1,249,597,000USD |
| Net Working Capital | 2,733,500,000USD | 2,049,300,000USD | 1,051,300,000USD | 792,300,000USD | -505,300,000USD | — | — | — |
| Unclassified Current Assets | -483,700,000USD | — | — | — | — | — | — | — |
| Unclassified Non Current Assets | 5,570,500,000USD | 46,700,000USD | 21,400,000USD | 7,600,000USD | — | — | — | — |
| Unclassified Current Liabilities | -29,833,700,000USD | -4,525,600,000USD | -3,100,900,000USD | -4,385,400,000USD | -138,300,000USD | — | — | — |
| Unclassified Non Current Liabilities | 23,331,100,000USD | 71,500,000USD | -864,800,000USD | 32,200,000USD | -116,400,000USD | 3,200,660,000USD | 2,078,070,000USD | 1,012,977,000USD |
| Unclassified Equity | 266,200,000USD | 276,900,000USD | 222,000,000USD | 223,900,000USD | 134,200,000USD | 134,327,000USD | 134,327,000USD | 134,516,000USD |
| Other Current Assets | — | 9,029,700,000USD | 4,329,500,000USD | 3,060,500,000USD | 1,113,000,000USD | — | — | — |
| Other Assets | — | -21,271,900,000USD | — | — | — | — | — | — |
| Current Deferred Revenue | — | 2,400,000USD | 500,000USD | 1,000,000USD | — | — | — | — |
| Non Current Liabilities Other | — | — | 907,900,000USD | 336,300,000USD | 136,600,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 112,400,000USD | 158,200,000USD | 73,200,000USD | 149,200,000USD | 72,500,000USD | 115,100,000USD | 58,400,000USD | 102,900,000USD |
| Capital Expenditures | 0USD | -4,300,000USD | 0USD | -8,800,000USD | 0USD | -6,400,000USD | 0USD | -9,200,000USD |
| Begin Period Cash Flow | 12,797,600,000USD | 3,375,300,000USD | 3,375,300,000USD | 5,469,500,000USD | 5,469,500,000USD | 4,603,900,000USD | 4,603,900,000USD | 4,165,900,000USD |
| Depreciation | — | 19,600,000USD | — | 16,500,000USD | — | — | — | 15,400,000USD |
| Stock Based Compensation | — | -16,500,000USD | — | 16,500,000USD | — | -9,700,000USD | — | — |
| Other Non Cash Items | — | -2,630,400,000USD | — | 2,583,200,000USD | — | -130,900,000USD | — | 30,300,000USD |
| Change To Account Receivables | — | 657,300,000USD | — | -3,227,500,000USD | — | -3,138,300,000USD | — | 380,400,000USD |
| Change To Inventory | — | -223,200,000USD | — | -198,800,000USD | — | 87,200,000USD | — | 40,400,000USD |
| Change In Working Capital | — | 2,208,900,000USD | — | -1,837,700,000USD | — | 736,500,000USD | — | 303,900,000USD |
| Total Cash From Operating Activities | — | -260,200,000USD | — | 927,700,000USD | — | 711,000,000USD | — | 452,500,000USD |
| Free Cash Flow | — | -264,500,000USD | — | 918,900,000USD | — | 704,600,000USD | — | 443,300,000USD |
| Total Cashflows From Investing Activities | — | -196,200,000USD | — | -68,100,000USD | — | -24,600,000USD | — | -10,700,000USD |
| Total Cash From Financing Activities | — | -43,500,000USD | — | -80,400,000USD | — | -33,400,000USD | — | -3,800,000USD |
| Dividends Paid | — | -28,200,000USD | — | -27,300,000USD | — | -26,400,000USD | — | -50,700,000USD |
| Sale Purchase Of Stock | — | 200,000USD | — | -44,300,000USD | — | — | — | -19,800,000USD |
| Change In Cash | — | 9,422,300,000USD | — | -5,469,500,000USD | — | 865,600,000USD | — | 438,000,000USD |
| End Period Cash Flow | — | 12,797,600,000USD | 3,375,300,000USD | 3,375,300,000USD | 5,469,500,000USD | 5,469,500,000USD | 1,914,200,000USD | 4,603,900,000USD |
| Other Cashflows From Investing Activities | — | 2,600,000USD | — | -2,600,000USD | — | 700,000USD | — | — |
| Other Cashflows From Financing Activities | — | -18,000,000USD | — | — | — | -7,000,000USD | — | -1,600,000USD |
| Unclassified Investing Cash Flow | — | -194,500,000USD | — | -56,700,000USD | — | -18,900,000USD | — | -1,500,000USD |
| Unclassified Financing Cash Flow | — | 2,500,000USD | — | -8,800,000USD | — | — | — | 68,300,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 307,400,000USD | 295,800,000USD | 141,300,000USD | 98,200,000USD | 56,500,000USD | 43,823,000USD | 36,392,000USD | 10,152,000USD |
| Depreciation | 36,100,000USD | 28,800,000USD | 21,900,000USD | 13,800,000USD | 10,300,000USD | 8,521,000USD | 7,634,000USD | 1,417,000USD |
| Stock Based Compensation | 43,500,000USD | 29,600,000USD | 20,300,000USD | 16,700,000USD | 1,200,000USD | — | — | — |
| Other Non Cash Items | -47,200,000USD | -231,100,000USD | -57,500,000USD | 118,900,000USD | 219,300,000USD | 518,549,000USD | -367,690,000USD | 293,553,999USD |
| Change To Account Receivables | -2,570,200,000USD | -2,757,900,000USD | 777,600,000USD | 3,141,100,000USD | -1,569,000,000USD | -365,081,000USD | 11,625,000USD | -214,284,000USD |
| Change To Inventory | -422,000,000USD | 127,600,000USD | -127,600,000USD | 44,300,000USD | -71,400,000USD | -8,774,000USD | — | — |
| Change In Working Capital | 371,200,000USD | 1,040,400,000USD | 609,000,000USD | -22,000,000USD | 183,500,000USD | -616,672,000USD | 300,525,000USD | -174,828,000USD |
| Total Cash From Operating Activities | 667,500,000USD | 1,163,500,000USD | 735,000,000USD | 225,600,000USD | 470,800,000USD | -45,779,000USD | -23,139,000USD | 130,294,999USD |
| Capital Expenditures | -13,100,000USD | -19,900,000USD | -12,100,000USD | -9,400,000USD | -7,300,000USD | -3,363,000USD | -2,759,000USD | -1,028,999USD |
| Free Cash Flow | 654,400,000USD | 1,143,600,000USD | 722,900,000USD | 216,200,000USD | 463,500,000USD | -49,142,000USD | -25,898,000USD | 129,265,999USD |
| Investments | -2,900,000USD | -35,300,000USD | -97,600,000USD | -46,300,000USD | -19,800,000USD | — | — | — |
| Total Cashflows From Investing Activities | -264,300,000USD | -35,300,000USD | -97,600,000USD | -46,300,000USD | -19,800,000USD | -31,052,000USD | -106,154,000USD | -2,594,000USD |
| Net Borrowings | -24,300,000USD | -8,600,000USD | -11,400,000USD | -56,600,000USD | -7,200,000USD | — | — | — |
| Total Cash From Financing Activities | -123,900,000USD | -37,200,000USD | -72,800,000USD | 26,500,000USD | -27,200,000USD | 150,876,000USD | 186,066,000USD | -56,197,000USD |
| Dividends Paid | -55,500,000USD | -77,100,000USD | -58,300,000USD | -6,600,000USD | -20,000,000USD | -18,195,000USD | — | — |
| Sale Purchase Of Stock | -44,100,000USD | -19,800,000USD | -3,100,000USD | -7,900,000USD | 0USD | — | — | — |
| Issuance Of Capital Stock | 0USD | 73,100,000USD | 0USD | 0USD | — | — | — | — |
| Change In Cash | 7,328,100,000USD | 1,073,100,000USD | 573,400,000USD | 198,100,000USD | 420,500,000USD | 74,045,000USD | 56,773,000USD | 71,504,000USD |
| Begin Period Cash Flow | 5,469,500,000USD | 1,483,500,000USD | 910,100,000USD | 1,328,500,000USD | 291,500,000USD | 217,501,000USD | 160,728,000USD | 89,224,000USD |
| End Period Cash Flow | 12,797,600,000USD | 2,556,600,000USD | 1,483,500,000USD | 3,248,700,000USD | 1,328,500,000USD | 291,546,000USD | 217,501,000USD | 160,728,000USD |
| Other Cashflows From Financing Activities | -18,000,000USD | -4,800,000USD | -97,600,000USD | -2,400,000USD | -19,800,000USD | -6,198,000USD | 186,066,000USD | -56,197,000USD |
| Unclassified Operating Cash Flow | -43,500,000USD | — | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | -248,300,000USD | 28,100,000USD | 16,800,000USD | 15,200,000USD | 10,800,000USD | -18,718,000USD | -110,150,000USD | — |
| Unclassified Financing Cash Flow | 18,000,000USD | 73,100,000USD | 97,600,000USD | 100,000,000USD | 19,800,000USD | 175,269,000USD | — | — |
| Other Cashflows From Investing Activities | — | -8,200,000USD | -4,700,000USD | -5,800,000USD | -3,500,000USD | -8,971,000USD | 6,755,000USD | -1,565,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q3 2012Quarterly · 2012-09-30 | Segment | Acne And Acne Related Dermatological Products | 85,109,000 | USD | 0001193125-12-461078 |
| Q3 2012Quarterly · 2012-09-30 | Segment | Non Acne Dermatological Products | 80,773,000 | USD | 0001193125-12-461078 |
| Q3 2012Quarterly · 2012-09-30 | Segment | Non Dermatological Products | 14,313,000 | USD | 0001193125-12-461078 |
| Q2 2012Quarterly · 2012-06-30 | Segment | Acne And Acne Related Dermatological Products | 93,131,000 | USD | 0001193125-12-344559 |
| Q2 2012Quarterly · 2012-06-30 | Segment | Non Acne Dermatological Products | 81,113,000 | USD | 0001193125-12-344559 |
| Q2 2012Quarterly · 2012-06-30 | Segment | Non Dermatological Products | 22,310,000 | USD | 0001193125-12-344559 |
| Q1 2012Quarterly · 2012-03-31 | Segment | Acne And Acne Related Dermatological Products | 108,501,000 | USD | 0001193125-12-218847 |
| Q1 2012Quarterly · 2012-03-31 | Segment | Non Acne Dermatological Products | 73,998,000 | USD | 0001193125-12-218847 |
| Q1 2012Quarterly · 2012-03-31 | Segment | Non Dermatological Products | 19,244,000 | USD | 0001193125-12-218847 |
| Q4 2011Quarterly · 2011-12-31 | Segment | Acne And Acne Related Dermatological Products | 101,874,000 | USD | Legacy provider |
| Q4 2011Quarterly · 2011-12-31 | Segment | Non Acne Dermatological Products | 64,004,000 | USD | Legacy provider |
| Q4 2011Quarterly · 2011-12-31 | Segment | Non Dermatological Products | 14,840,000 | USD | Legacy provider |
| FY 2011Yearly · 2011-12-31 | Segment | Acne And Acne Related Dermatological Products | 447,585,000 | USD | 0001193125-12-082132 |
| FY 2011Yearly · 2011-12-31 | Segment | Non Acne Dermatological Products | 229,603,000 | USD | 0001193125-12-082132 |
| FY 2011Yearly · 2011-12-31 | Segment | Non Dermatological Products | 43,938,000 | USD | 0001193125-12-082132 |
| Q3 2011Quarterly · 2011-09-30 | Segment | Acne And Acne Related Dermatological Products | 119,119,000 | USD | 0001193125-12-461078 |
| Q3 2011Quarterly · 2011-09-30 | Segment | Non Acne Dermatological Products | 55,659,000 | USD | 0001193125-12-461078 |
| Q3 2011Quarterly · 2011-09-30 | Segment | Non Dermatological Products | 9,890,000 | USD | 0001193125-12-461078 |
| Q2 2011Quarterly · 2011-06-30 | Segment | Acne And Acne Related Dermatological Products | 123,130,000 | USD | 0001193125-12-344559 |
| Q2 2011Quarterly · 2011-06-30 | Segment | Non Acne Dermatological Products | 57,719,000 | USD | 0001193125-12-344559 |
| Q2 2011Quarterly · 2011-06-30 | Segment | Non Dermatological Products | 9,978,000 | USD | 0001193125-12-344559 |
| Q1 2011Quarterly · 2011-03-31 | Segment | Acne And Acne Related Dermatological Products | 103,462,000 | USD | 0001193125-12-218847 |
| Q1 2011Quarterly · 2011-03-31 | Segment | Non Acne Dermatological Products | 52,221,000 | USD | 0001193125-12-218847 |
| Q1 2011Quarterly · 2011-03-31 | Segment | Non Dermatological Products | 9,230,000 | USD | 0001193125-12-218847 |
| FY 2010Yearly · 2010-12-31 | Segment | Acne And Acne Related Dermatological Products | 482,359,000 | USD | 0001193125-12-082132 |
| FY 2010Yearly · 2010-12-31 | Segment | Non Acne Dermatological Products | 174,978,000 | USD | 0001193125-12-082132 |
| FY 2010Yearly · 2010-12-31 | Segment | Non Dermatological Products | 38,595,000 | USD | 0001193125-12-082132 |
| Q3 2010Quarterly · 2010-09-30 | Segment | Acne And Acne Related Dermatological Products | 118,506,000 | USD | 0001193125-11-304486 |
| Q3 2010Quarterly · 2010-09-30 | Segment | Non Acne Dermatological Products | 49,499,000 | USD | 0001193125-11-304486 |
| Q3 2010Quarterly · 2010-09-30 | Segment | Non Dermatological Products | 9,091,000 | USD | 0001193125-11-304486 |
| FY 2009Yearly · 2009-12-31 | Segment | Acne And Acne Related Dermatological Products | 398,861,000 | USD | 0001193125-12-082132 |
| FY 2009Yearly · 2009-12-31 | Segment | Non Acne Dermatological Products | 133,595,000 | USD | 0001193125-12-082132 |
| FY 2009Yearly · 2009-12-31 | Segment | Non Dermatological Products | 38,191,000 | USD | 0001193125-12-082132 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.